Faron Pharmaceuticals Oy (GB:FARN) has released an update.
Faron Pharmaceuticals Oy is seeking to raise approximately EUR 30.7 million through a new retail offer of ordinary shares on the REX platform, specifically targeting UK retail investors. The offering is set to include a significant discount on the share price and is conditional upon the successful completion of other public and institutional offerings. Interested UK investors have until June 19, 2024, to participate via specific financial intermediaries, with a minimum subscription of £50 required.
For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.
